Head and Neck Cancer Market Analysis Report, Regional Outlook with Key Players | AB Science SA, Bayer AG, Bristol-Myers Squibb Company, Acceleron Pharma, Astellas Pharma, Boston Biomedical, AbbVie, AstraZeneca

Coherent Market Insights has announced the addition of the “Head and Neck Cancer Market Size Status and Forecast 2026”, The report classifies the global Head and Neck Cancer Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.

This report studies the global Head and Neck Cancer Speaker market, analyzes and researches the Head and Neck Cancer Market Speaker development status and forecast in North America, Europe, Asia Pacific, Latin America and Rest of the World. This report focuses on the top players in global market, like AB Science SA, Bayer AG, Bristol-Myers Squibb Company, Acceleron Pharma, Astellas Pharma, Boston Biomedical, AbbVie, AstraZeneca

Request sample a copy: https://www.coherentmarketinsights.com/insight/request-sample/530

Cancer is the uncontrolled and abnormal growth of cells that results in formation of a mass called tumor. This tumor can be cancerous or benign. Head and neck cancer is the terminology used to define a number of different malignant tumors that develop in or around the throat, larynx, nose, sinuses, and mouth. Furthermore, head and neck cancers initiate in squamous cells, cells that line moist surfaces such as those inside the head and neck (for example, the mouth, nose, and throat). Salivary glands have different types of cells that can turn cancerous. Chewing tobacco, excessive alcohol consumption, and infection with human papillomavirus (HPV) increases the risk of head and neck cancer. Other risk factors for head and neck cancers include excessive consumption of paan (betel quid), preserved or salted foods, oral health, occupational exposure, radiation exposure, Epstein barr virus infection, and due to hereditary causes.

According to National Center for Biotechnology Information, head and neck cancer is the sixth-most common cancer worldwide, with around 630,000 new patients diagnosed every year, in turn resulting in over 350,000 deaths. Symptoms include a change or hoarseness in the voice, a lump or sore that does not heal, sore throat that does not go away, and unexplained and prolonged trouble swallowing. Around 75% of head and neck cancers are associated with tobacco use, including smokeless tobacco. Infection with HPV is a risk factor for some head and neck cancers.

Increasing geriatric population and rising number of initiatives by government and non-governmental organizations such as Support for People with Oral and Head and Neck Cancer (SPOHNC) creates a highly conducive environment for growth of the global head and neck cancer market.

On the basis of disease indication, the global head and neck cancer market is classified into:

Laryngeal and Hypopharyngeal Cancer
Nasal Cavity and Paranasal Sinus Cancer
Nasopharyngeal Cancer
Oral and Oropharyngeal Cancer
Salivary Gland Cancer

On the basis of diagnostic methods, the global head and neck cancer market is classified into:

Diagnostic imaging equipment
Endoscopy screening equipment
Bioscopy screening tests
Blood tests

Growing occurrence of head and neck cancer and increasing research activities to develop cost-effective treatment options are the factors which are driving growth of the global head and neck cancer market. According to the World Health Organization, 3 - 5% of the population around the globe suffers from head and neck cancer. Moreover, worldwide approximately 550,000 new cases of head and neck cancer are diagnosed annually with almost 300,000 deaths annually. While the cancer can affect people across different age groups, it is especially prevalent among people over 50 years of age. Head and neck cancer is projected to result in 13,360 fatalities (3,420 women and 9,940 men) in 2017. These types of cancers are more than twice as common among men as women.

Else place an Inquire before Purchase “Head and Neck Cancer Market Size, Status and Forecast 2026 : https://www.coherentmarketinsights.com/insight/talk-to-analyst/530

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.